Warner-Lambert Sales Productivity Would Be Focus Of Pfizer Integration
Executive Summary
One focus of Pfizer's integration of Warner-Lambert would be on raising the productivity of the Parke-Davis sales organization to Pfizer's "best-in-class" level, Pfizer told a Nov. 16 meeting with securities analysts.
You may also be interested in...
Celexa Scripts For Patients Under 20 Account For 4% Of Use - Forest
Forest/Warner-Lambert's antidepressant Celexa (citalopram) is seeing some off-label use in the pediatric/adolescent patient population; about 4% of Celexa use has been in patients under 20 years old.
Celexa Scripts For Patients Under 20 Account For 4% Of Use - Forest
Forest/Warner-Lambert's antidepressant Celexa (citalopram) is seeing some off-label use in the pediatric/adolescent patient population; about 4% of Celexa use has been in patients under 20 years old.
Pfizer Faces $2 Bil. Annual Goodwill Charges If Pooling Not Allowed In WL Bid
Pfizer would incur goodwill expenses of approximately $2 bil. per year if it is required to use the purchase accounting method in its acquisition of Warner-Lambert, Pfizer said in a Nov. 15 court filing.